This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gaynor, P. M. Articles by Kruth, H. S. Search for Related Content PubMed PubMed Citation Articles by Gaynor, P. M. Articles by Kruth, H. S.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:992.)
© 1996 American Heart Association, Inc.

Articles

Accumulation of HDL Apolipoproteins Accompanies Abnormal Cholesterol Accumulation in Schnyder's Corneal Dystrophy

Paulette M. Gaynor; Wei-Yang Zhang; Jayne S. Weiss; Sonia I. Skarlatos; Merlyn M. Rodrigues; Howard S. Kruth

the Section of Experimental Atherosclerosis, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.M.G., W.-Y.Z., S.I.S., H.S.K.); Department of Ophthalmology, University of Massachusetts Medical Center, Worcester (J.S.W.); and Department of Ophthalmology, University of Maryland Medical School, Baltimore (M.M.R.).

Correspondence to Howard S. Kruth, MD, Section of Experimental Atherosclerosis, NHLBI, National Institutes of Health, Bldg 10, Room 5N-113, 10 Center Dr MSC 1422, Bethesda, MD 20892-1422.

Abstract

Schnyder's corneal dystrophy is an autosomal dominant disorder that results in clouding of the central cornea and premature development of peripheral arcus in the cornea. Previous studies showed that abnormal lipid accumulation is the basis for the corneal clouding. We examined whether apolipoproteins are involved in this disorder and characterized the lipid accumulation in the central portion of corneas removed from patients with Schnyder's dystrophy. Our findings show that cholesterol and phospholipid contents increased greater than 10-fold and 5-fold, respectively, in affected compared with normal corneas. In addition, the percentage of cholesterol that was unesterified (63% versus 50%) and the molar ratio of unesterified cholesterol to phospholipid (1.5 versus 0.5) were higher in affected compared with normal corneas. Large multilamellar vesicles and electron-dense granules (100 to 300 nm in diameter) as well as cholesterol crystals accumulated in the extracellular matrix of affected corneas. Immunohistochemical analysis showed that apolipoprotein constituents of HDL (apoA-I, apoA-II, and apoE), but not apoB, a marker of LDL, accumulated in the affected cornea. Western blot analysis confirmed the increased amounts of these HDL apolipoproteins in affected corneas and showed that the apparent molecular weights of the apolipoproteins were normal. Our findings show for the first time that HDL apolipoproteins accumulate in the corneas of patients with Schnyder's corneal dystrophy. Thus, this disorder influences the metabolism of HDL in the corneas of these patients.

Key Words: cholesterol • Schnyder's corneal dystrophy • apolipoproteins • lipoproteins • atherosclerosis

This article has been cited by other articles:

				J. S. Weiss, H. S. Kruth, H. Kuivaniemi, G. Tromp, P. S. White, R. S. Winters, W. Lisch, W. Henn, E. Denninger, M. Krause, et al. Mutations in the UBIAD1 Gene on Chromosome Short Arm 1, Region 36, Cause Schnyder Crystalline Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5007 - 5012. [Abstract] [Full Text] [PDF]

				M. Yamada, H. Mochizuki, Y. Kamata, Y. Nakamura, and Y. Mashima Quantitative analysis of lipid deposits from Schnyder's corneal dystrophy Br. J. Ophthalmol., April 1, 1998; 82(4): 444 - 447. [Abstract] [Full Text]